Hepatitis B virus reactivation in a case of Waldenstrom's Macroglobulinemia treated with chemotherapy and rituximab despite adefovir prophylaxis [7]

American Journal of Hematology

Volumn 82, Issue 7, 2007, Pages 688-

  Khaled, Yasser ^a   Hanbali, Amr ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; CD20 ANTIGEN; FLUDARABINE; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LAMIVUDINE; RITUXIMAB; VIRUS DNA;

ADULT; ANEMIA; ANTIVIRAL ACTIVITY; CASE REPORT; EARLY DIAGNOSIS; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOTHERAPY; LETTER; LIVER FAILURE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; VIRUS REACTIVATION; WALDENSTROEM MACROGLOBULINEMIA;

ADENINE; ADULT; ANTIBODIES, MONOCLONAL; FEMALE; HEPATITIS B VIRUS; HUMANS; IMMUNOTHERAPY; PHOSPHONIC ACIDS; WALDENSTROM MACROGLOBULINEMIA;

EID: 34347361524     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20861     Document Type: Letter

References (5)

1. Vassiliadis T, Garipidou V, Tziomalos K, Perifanis V, Giouleme O, Vakalopoulou S. Prevention of hepatitis B reactivation with lumivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy-A prospective case series. Am J Hematol 2005;80:197-203.
2. Tsutsumi Y, Kanamori H, Mori A, Tanaka J, Asaka M, Imamura M, Masauzi N. Reactivation of hepatitis B virus with rituximab. Expert Opin Drug Saf 2005;4:599-608.
3. Dai MS, Chao TY, Kao WY, Shyu RY, Liu TM. Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP. Ann Hematol 2004;83:769-774.
4. Sarrecchia C, Cappelli A, Aiello P. HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb. J Infect Chemother 2005;11:189-191.
5. Law JK, Ho JK, Hoskins PJ, Erb SR, Steinbrecher UP, Yoshida EM. Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: Potential implications for future prophylaxis recommendations. Leuk Lymphoma 2005;46:1085-1089.